Second Edition of Medicinal Chemistry in Asia
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: 15 September 2024 | Viewed by 12403
Special Issue Editors
Interests: diabetes; hyperlipidemia; obesity; Inflammation; molecular pharmacology
Special Issues, Collections and Topics in MDPI journals
Interests: pharmaceutics; nanomedicine; medicinal chemistry; drug delivery; biomaterials; anticancer drugs; cancer therapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue is entitled “Second Edition of Medicinal Chemistry in Asia”. In Asia, many research groups, both from industry and academia, are working on medicinal chemistry topics that cover almost all therapeutic fields, ranging from anticancer and antimicrobial agents to compounds potentially active in diabetes, hyperlipidemia, obesity, non-alcoholic fatty liver diseases, cardiovascular diseases, nervous system disease, gastrointestinal disorders, and immune and inflammatory dysfunction. The results obtained—often proving to be very important and recognized all over the world—are derived from the close collaboration of experts in different areas, such as computational chemistry, organic chemistry, nanomedicine, cellular and molecular biology, biochemistry, and pharmacology.
Scientists from Asia are cordially invited to contribute original research papers or reviews to this Special Issue of Molecules, which reports on the design, synthesis, and evaluation of potentially active compounds and action mechanisms in the different subjects of medicinal chemistry.
Dr. Wei-dong Xie
Dr. Xiaowei Zeng
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- glucose and lipid-regulating drugs
- immunomodulatory and anti-inflammatory drugs
- cardiovascular protective drugs
- anticancer and antimicrobial drugs
- gastrointestinal regulating drugs
- nanomedicine and drug delivery system
